The Nucleotide Excision Repair Pathway Limits L1 Retrotransposition.

Area of Science:

• Genetics
• Molecular Biology
• Genomics

Background:

• Long interspersed elements 1 (L1) are mobile genetic elements comprising 17% of the human genome.
• L1 retrotransposition can cause genetic diseases through de novo insertions.
• The ERCC1-XPF endonuclease complex is known to limit L1 retrotransposition.

Purpose of the Study:

• To investigate the role of the nucleotide excision repair (NER) pathway in preventing L1 retrotransposition.
• To determine if NER proteins are involved in limiting the insertion of retroelements into the genome.
• To explore the potential role of NER in preventing genomic instability at retrotransposon insertion sites.

Main Methods:

• Monitoring retrotransposition efficiencies of engineered L1 elements in NER-deficient and complemented cell lines.
• Analyzing de novo L1 inserts and their genomic locations in NER-deficient cells.
• Assessing the involvement of core NER proteins (XPD, XPA) and XPC in L1 retrotransposition.

Main Results:

• NER-deficient cells exhibited increased L1 retrotransposition efficiencies.
• Core NER proteins (XPD, XPA) and XPC were found to limit L1 retrotransposition.
• Abnormally large duplications were observed at L1 insertion sites in NER-deficient cells.

Conclusions:

• The NER pathway plays a significant role in limiting L1 retrotransposition and preventing insertional mutations.
• NER proteins are involved in preventing potentially mutagenic large genomic duplications at retrotransposon insertion sites.
• NER pathway contributes to genome integrity by suppressing retrotransposon-mediated mutations and duplications.